Healthcare / Medical DistributionWarsaw
$7.56
+0.00 (+0.00%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 17%
FCF escenarios
weak_data · normalized FCF $-44.7M · quality 39.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
44/100
C
Piotroski
4/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$4.0B
P/E
6.1x
↓EV/EBITDA
12.1x
↓ROE
13.6%
↑Gross Margin
23.4%
↓Debt/Equity
0.65
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+16.2%
FCF CAGR
—
FCF margin
-4.8%
FCF / Net income
-0.96x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $2.61B · net income $129.2M · FCF $-124.2M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $2.61B | $2.61B | $2.13B | $1.88B | $1.66B |
| Net Income | $129.2M | $129.2M | $76.3M | $96.0M | $71.1M |
| EBITDA | $258.9M | $258.9M | $165.9M | $178.2M | $143.3M |
| EPS | 0.38 | 0.38 | 0.46 | 0.69 | 0.57 |
| Gross Margin | 23.4% | 23.4% | 21.3% | 21.7% | 21.4% |
| Operating Margin | 5.6% | 5.6% | 4.1% | 5.2% | 5.3% |
| Net Margin | 4.9% | 4.9% | 3.6% | 5.1% | 4.3% |
| Balance Sheet | |||||
| Debt/Equity | 0.65 | 0.65 | 0.59 | 0.48 | 0.38 |
| Current Ratio | 1.30 | 1.30 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-124.2M | $-124.2M | $-44.7M | $1.7M | $86.4M |
| Returns | |||||
| ROE | 13.6% | 13.6% | 9.3% | 13.0% | 10.1% |
| Valuation | |||||
| P/E | 6.10 | 6.10 | 26.63 | 23.04 | 18.25 |
| EV/EBITDA | 12.12 | 12.12 | 14.85 | 13.58 | 10.77 |
| P/B | 2.74 | 2.74 | 2.47 | 2.98 | 1.84 |
| Growth & Yield | |||||
| Revenue Growth | 22.6% | 22.6% | 13.5% | 12.8% | — |
| EPS Growth | -17.4% | -17.4% | -33.3% | 21.1% | — |
| Dividend Yield | 5.1% | 5.1% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
20.9%
EPS terminal req.
$0.67
Spread vs growth
-38.2%
5Y implied EPS CAGR
16.4%
EPS terminal req.
$0.81
Spread vs growth
-33.8%
10Y implied EPS CAGR
13.2%
EPS terminal req.
$1.31
Spread vs growth
-30.5%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-36.2%
Start / end P/E
27.1x → 19.2x
EPS bridge
0.46 → 0.38
Residual
+5.0%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.